Femtech, technology and software addressing women’s biological needs, has seen venture capital funding triple from $600 million in 2015 to $1.9 billion in 2021 as early stage investors have an increased interest in tech companies focused on women’s health conditions. Here are key points highlighting market growth:
- Firms focused on gynecology, fertility and maternity have garnered the largest funding.
- Femtech funding is being driven by the growth in large employers adopting services focused on maternal and family health.
- The vast majority of femtech firms are led by women.
Despite the increase in venture fund investments, analysts say the overall investment in women’s health still remains underfunded.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.